Calendar

Immovable lifecycle review calendar

Blue dots are upcoming. Completed reviews turn green for correct thesis, red for wrong thesis, and orange when timing was off.

0

0 post-mortem tasks pending in tasks/pending/

This Month

6

0 upcoming, 6 historical review dates.

Completed

6

Review dates with post-mortems already ingested.

Month View

April 2026

Selected Date

23 Apr 2026

ICICI Bank

ICICIBANK • REVIEW_COMPLETE • earnings play

Hold 7 days • Review / exit 23 Apr 2026

+3.25% Post-mortem done
Thesis

ICICI Bank reports Q4 FY26 on April 26 with strong expectations — analysts forecast PAT of Rs 11,500-12,200 Cr and NIM of 4.0-4.1%. Multiple brokerages (MOFSL, YES Securities, CLSA, Emkay) have Buy ratings with targets of Rs 1,420-1,500. Currently trading at Rs 1,351, implying 5-11% upside to consensus targets. The stock benefits from RBI's accommodative stance, strong credit growth, and improving asset quality. DII accumulation in banking provides institutional support.

Prices

Entry: ₹1,345.50

Current: ₹1,389.20

P&L: +3.25%

Hold Plan

Target hold: 7 days

Held so far: 6 days

Review / exit: 23 Apr 2026

Review complete

Assumptions

A1: ICICI Bank Q4 PAT exceeds Rs 11,500 Cr with NIM above 4.0%

A2: Loan growth sustains at 14%+ in Q4 FY26

Lifecycle Timeline
Bought 16 Apr 2026

Accepted from analysis task analysis-2026-04-16-1724

Confirmed and held 17 Apr 2026

Q4 FY26 results are on April 18 (corrected from the thesis note of April 26) — just one trading day away. Stock is essentially flat at ₹1,343.90 vs entry of ₹1,345.50 with all the upside still ahead. Brokerage targets of ₹1,420-1,500 (5-11% upside) and analyst PAT consensus of ₹11,500-12,200 cr support holding through the event.

Sold 21 Apr 2026

ICICI Bank closed near Rs 1,388.65, up about 3.2% from the Rs 1,345.50 entry, and the Q4 earnings catalyst has already occurred with profit growth and asset-quality improvement. Because this was an earnings-play thesis, the event is now largely monetized; exit locks the gain rather than converting it into an unplanned long hold.

Reviewed and closed 23 Apr 2026

Post-mortem postmortem-REC-20260416-03-ICICIBANK-2026-04-23 completed on 2026-04-23T10:57:10Z.

Post-Mortem

correct

Exit correct
Review Return

Review price: ₹1,348.00

Full hold: +0.19%

Actual: +3.25%

Benchmarks

NIFTY 50: -0.10%

Excess: +0.29%

Sector excess: -0.20%

What If

Held full: +0.19%

Exited at WATCH: +3.25%

Thesis Analysis

Q4 results beat the thesis: PAT was Rs 13,702 crore, NIM stayed above 4%, and loan growth was above 14%. The only miss was the original event date.

Exit Analysis

Exiting after the earnings reaction protected the 3.25% gain. Holding to review date would have reduced the return to roughly flat despite correct fundamentals.

Verified Assumptions
A1 Verified

PAT exceeded Rs 11,500 crore and reported NIM was above 4%.

A2 Verified

Loan growth was reported around 15.8% YoY.

Lessons
high earnings_play exit discipline

Earnings plays should be monetized quickly after the catalyst unless post-result price action confirms continuation.

high event_date_primary_source_required

Verify earnings dates from exchange or company filings before accepting preview-source dates.

Corporate Events
earnings 18 Apr 2026

upcoming